Induction of rat hepatic mixed function monooxygenases by levamisole

Area of Science:

• Pharmacology and Toxicology
• Biochemistry
• Drug Metabolism

Background:

• Hepatic microsomal enzymes are crucial for drug metabolism and detoxification.
• Levamisole is an anthelmintic and immunomodulatory drug with potential effects on liver function.
• Understanding drug-induced changes in hepatic metabolism is vital for assessing drug safety and efficacy.

Purpose of the Study:

• To investigate the impact of levamisole on key parameters of hepatic microsomal metabolism in female rats.
• To quantify changes in the metabolic activity of specific drug substrates.
• To assess alterations in the levels of critical microsomal proteins involved in metabolism.

Main Methods:

• Female rats were administered levamisole (20 mg/kg, i.p. daily for 10 days).
• Hepatic microsomes were isolated for in vitro metabolic assays.
• Metabolism of aminopyrine and aniline was measured.
• Levels of cytochrome P-450 and cytochrome b5 were quantified.

Main Results:

• Levamisole pretreatment significantly increased the in vitro metabolism of aminopyrine.
• Levamisole pretreatment significantly increased the in vitro metabolism of aniline.
• Microsomal content of cytochrome P-450 and cytochrome b5 showed significant increases.

Conclusions:

• Levamisole administration enhances hepatic microsomal metabolic activity in female rats.
• The drug appears to induce key enzymes involved in drug metabolism, including cytochrome P-450 and cytochrome b5.
• These findings suggest that levamisole can alter liver drug-metabolizing capacity.